Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

J Clin Oncol. 2019 Apr 10;37(11):858-861. doi: 10.1200/JCO.18.01360. Epub 2019 Feb 11.
No abstract available

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / therapy
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Female
  • Humans
  • Practice Guidelines as Topic
  • Premenopause
  • Randomized Controlled Trials as Topic
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen